Skip to Content
Merck
CN

Synthesis of N-peptide-6-amino-D-luciferin Conjugates.

Frontiers in chemistry (2018-05-05)
Anita K Kovács, Péter Hegyes, Gábor J Szebeni, Lajos I Nagy, László G Puskás, Gábor K Tóth
ABSTRACT

A general strategy for the synthesis of N-peptide-6-amino-D-luciferin conjugates has been developed. The applicability of the strategy was demonstrated with the preparation of a known substrate, N-Z-Asp-Glu-Val-Asp-6-amino-D-luciferin (N-Z-DEVD-aLuc). N-Z-DEVD-aLuc was obtained via a hybrid liquid/solid phase synthesis method, in which the appropriately protected C-terminal amino acid was coupled to 6-amino-2-cyanobenzothiazole and the resulting conjugate was reacted with D-cysteine in order to get the protected amino acid-6-amino-D-luciferin conjugate, which was then attached to resin. The resulting loaded resin was used for the solid-phase synthesis of the desired N-peptide-6-amino-D-luciferin conjugate without difficulties, which was then attested with NMR spectroscopy and LC-MS, and successfully tested in a bioluminescent system.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Chlorobenzothiazole, 99%
Sigma-Aldrich
Chloro-N,N,N′,N′-tetramethylformamidinium hexafluorophosphate, ≥98.0% (T)
Sigma-Aldrich
Fluoro-N,N,N′,N′-tetramethylformamidinium hexafluorophosphate, 97%